Item Type No Grouping

Article

The influence of oily vehicle composition and vehicle-membrane interactions on the diffusion of model permeants across barrier membranes. (2021) Omaima N. Najib, Gary P. Martin, Stewart B. Kirton, Michelle J. Botha, Al Sayed Sallam and Darragh Murnane

Multivariate analytical approaches to identify key molecular properties of vehicles, permeants and membranes that affect permeation through membranes. (2020) Omaima N. Najib, Stewart B. Kirton, Gary P. Martin, Michelle J. Botha, Al Sayed Sallam and Darragh Murnane

Formulation pre-screening of inhalation powders using computational atom-atom systematic search method. (2015) Vasuki Ramachandran, Darragh Murnane, Robert B. Hammond, Jonathan Pickering, Kevin J. Roberts, Majeed Soufian, Ben Forbes, Sara Jaffari, Gary P. Martin, Elizabeth Collins and Klimentina Pencheva

Evidence for the existence of powder sub-populations in micronized materials : Aerodynamic size-fractions of aerosolized powders possess distinct physicochemical properties. (2014) Sara Jaffari, Ben Forbes, Elizabeth Collins, Jiyi Khoo, Gary P. Martin and Darragh Murnane

Rapid characterisation of the inherent dispersibility of respirable powders using dry dispersion laser diffraction. (2013) Sara Jaffari, Ben Forbes, Elizabeth Collins, David J. Barlow, Gary P. Martin and Darragh Murnane

The application and limitations of mathematical modelling in the prediction of permeability across mammalian skin and polydimethylsiloxane membranes. (2011) Gary Moss, Yi Sun, Simon C. Wilkinson, N. Davey, Roderick Adams, Gary P. Martin, M. Prapopopolou and Marc Brown

Short-term iontophoretic and post-iontophoretic transport of model penetrants across excised human epidermis. (2009) Franklin K. Akomeah, Gary P. Martin and Marc Brown

Dry Powder Formulations for Inhalation of Fluticasone Propionate and Salmeterol Xinafoate Microcrystals. (2009) Darragh Murnane, Gary P. Martin and Christopher Marriott

Investigations into the formulation of metered dose inhalers of salmeterol xinafoate and fluticasone propionate microcrystals. (2008) Darragh Murnane, Gary P. Martin and Christopher Marriott

Polymorphic control of inhalation microparticles prepared by crystallization. (2008) Darragh Murnane, Christopher Marriott and Gary P. Martin

In situ and Ex situ analysis of salmeterol xinafoate microcrystal formation from poly(ethylene glycol) 400 - Water cosolvent mixtures. (2008) Darragh Murnane, Christopher Marriott and Gary P. Martin

Comparison of salmeterol xinafoate microparticle production by conventional and novel antisolvent crystallization. (2008) Darragh Murnane, Christopher Marriott and Gary P. Martin

Developing an environmentally benign process for the production of microparticles : Amphiphilic crystallization. (2008) Darragh Murnane, Christopher Marriott and Gary P. Martin

Effect of abrasion induced by a rotating brush on the skin permeation of solutes with varying physicochemical properties. (2008) Franklin K. Akorneah, Gary P. Martin, Andy G. Muddle and Marc Brown

Variability in human skin permeability in vitro: Comparing penetrants with different physicochemical properties. (2007) Franklin K. Akomeah, Gary P. Martin and Marc Brown

Stabilisation of deoxyribonuclease in hydrofluoroalkanes using miscible vinyl polymers. (2006) Stuart A. Jones, Gary P. Martin and Marc Brown

The effects of polyvinyl alcohol on the in vitro stability and delivery of spray-dried protein particles from surfactant-free HFA 134a-based pressurised metered dose inhalers. (2005) Y. H. Liao, Stuart A. Jones, T. Nazir, Gary P. Martin and Marc Brown

High-pressure aerosol suspensions : A novel laser diffraction particle sizing system for hydrofluoroalkane pressurised metered dose inhalers. (2005) Stuart A. Jones, Gary P. Martin and Marc Brown

Investigation of the stabilisation of freeze-dried lysozyme and the physical properties of the formulations. (2004) Y. H. Liao, Gary P. Martin and Marc Brown

Determination of polyvinylpyrrolidone using high-performance liquid chromatography. (2004) Stuart A. Jones, Gary P. Martin and Marc Brown

An investigation of calibration methods for solution calorimetry. (2004) B. T. S. Yff, P.G. Royall, Marc Brown and Gary P. Martin

Investigation of the physical properties of spray-dried stabilised lysozyme particles. (2003) Y. H. Liao, Marc Brown, A. Quader and Gary P. Martin

In vivo evaluation of novel hyaluronan/chitosan microparticulate delivery systems for the nasal delivery of gentamicin in rabbits. (2002) S. T. Lim, B. Forbes, D. J. Berry, Gary P. Martin and Marc Brown

An in vitro technique for evaluating inhaled nasal delivery systems. (2002) B. Forbes, S. Lim, Gary P. Martin and Marc Brown

An in vitro investigation into the effect of glycosaminoglycans on the skin partitioning and deposition of NSAIDs. (2001) Marc Brown, M Hanpanitcharoen and Gary P. Martin

Activation of clindamycin phosphate by human skin. (2001) S. Amr, Marc Brown, Gary P. Martin and B. Forbes

Turbidimetric and HPLC assays for the determination of formulated lysozyme activity. (2001) Y. H. Liao, Marc Brown and Gary P. Martin

Mitigation of surfactant erythrocyte toxicity by egg phosphatidylcholine. (2000) L. A. Gould, A. B. Lansley, Marc Brown, B. Forbes and Gary P. Martin

Preparation and evaluation of the in vitro drug release properties and mucoadhesion of novel microspheres of hyaluronic acid and chitosan. (2000) S. T. Lim, Gary P. Martin, D. J. Berry and Marc Brown

The influence of hydrocolloid patch composition on the bioavailability of triamcinolone acetonide in humans. (2000) Gary P. Martin, D. Ladenheim, C. Marriott, D.A. Hollingsbee and Marc Brown

High performance liquid chromatography of a cyclosporin A formulation on a porous graphitic carbon column. (1997) T. Nazir, L. A. Gould, C. Marriott, Gary P. Martin and Marc Brown

An in-vitro study of the effect of hydrocolloid patch occlusion on the penetration of triamcinolone acetonide through skin in man. (1996) D. Ladenheim, Gary P. Martin, C. Marriott, D. A. Hollingsbee and Marc Brown

The effect of hyaluronan on the in vitro deposition of diclofenac within the skin. (1995) Marc Brown, C. Marriott and Gary P. Martin

Other

Dermal and transdermal drug delivery systems : Current and future prospects. (2006) Marc Brown, Gary P. Martin, S. A. Jones and F. K. Akomeah

Hyaluronan: Investigations into the mode of action of hyaluronan in topical drug delivery. (2006) Marc Brown, Stuart A. Jones, Weijiang He and Gary P. Martin

Hyaluronan: Pharmaceutical characterization and drug delivery. (2005) Y. H. Liao, Stuart A. Jones, B. Forbes, Gary P. Martin and Marc Brown

Effect of molecular weight and concentration hyaluronan on the in-vitro release characteristics of ibuprofen and diclofenac sodium across cellulose membrane. (2004) W. J. He, Marc Brown and Gary P. Martin

An in vitro investigation of the mode of action of hyaluronan as a drug delivery vehicle using circular dichroism. (1995) Marc Brown, G. Siligardi, Gary P. Martin, A. Drake and C. Marriott

A preliminary study of the effect of hyaluronan on the deposition of C-14-labelled diclofenac within human skin using autoradiography. (1995) Marc Brown, S. Ingham, A. Moore, Gary P. Martin and C. Marriott

A study of the transdermal drug delivery properties of hyaluronan. (1995) Marc Brown, C. Marriott and Gary P. Martin

The use of hyaluronan in transdermal drug delivery : Physiological barriers and regulatory issues. (1995) C. Marriott, Gary P. Martin and Marc Brown